267 results on '"Hissar, Syed"'
Search Results
2. Sex-specific differences in systemic immune responses in MIS-C children
3. Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial
4. Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity
5. Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
6. Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4: 1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV
7. Paediatric pulmonary disease—are we diagnosing it right?
8. Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population.
9. Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial.
10. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity
11. Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
12. Multisystem inflammatory syndrome in children characterized by enhanced antigen-specific T-cell expression of cytokines and its reversal following recovery
13. Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis
14. The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India
15. Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis
16. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
17. Multisystem inflammatory syndrome in children characterized by enhanced antigen-specific T-cell expression of cytokines and its reversal following recovery.
18. Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis
19. Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children
20. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children
21. Unique cellular immune signatures of multisystem inflammatory syndrome in children
22. Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection
23. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen–Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery
24. Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis
25. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial
26. Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children
27. Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis
28. Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure
29. Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India
30. Impaired Monocyte-Macrophage Functions and Defective Toll-Like Receptor Signaling in Hepatitis E Virus-Infected Pregnant Women With Acute Liver Failure
31. Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
32. Additional file 1 of Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis
33. Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats
34. Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis
35. Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey
36. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF)
37. Circulating Tregs Correlate with Viral Load Reduction in Chronic HBV-Treated Patients with Tenofovir Disoproxil Fumarate
38. Gene Expression Profiles of T Cells from Hepatitis E Virus Infected Patients in Acute and Resolving Phase
39. Impaired Antigen Processing and Presentation Machinery is Associated with Immunotolerant State in Chronic Hepatitis B Virus Infection
40. Drug resistant TB spine in a two year old child: A case report
41. Interleukin-28b CC Genotype Predicts Early Treatment Response and CT/TT Genotypes Predicts Non-Response in Patients Infected with HCV Genotype 3
42. Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients
43. Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations.
44. The hepatitis C virus NS5A protein and response to interferon α: mutational analyses in patients with chronic HCV genotype 3a infection from India
45. Additional file 2 of The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India
46. Additional file 1 of The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India
47. Decrease in CD4 + T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine
48. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
49. Decreased Expression of CXCR5 on CD4 T Cells is Associated with Fatal Acute Liver Failure (ALF) in HEV Infected Pregnant Patients: 1974
50. Decline in Serum HBV DNA Levels More Accurately Predict Seroconversion During Tenofovir Therapy Than Hepatitis B Surface Antigen Levels in HBeAg Positive Patients with Chronic Hepatitis B: 472
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.